Información de la revista
Vol. 25. Núm. 8.
Páginas 508-513 (enero 2002)
Vol. 25. Núm. 8.
Páginas 508-513 (enero 2002)
Acceso a texto completo
Tratamiento actual del tumor carcinoide
Visitas
19494
Servicio de Aparato Digestivo. Hospital de Navarra. Pamplona. España
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
V. Ortiz, D. Nicolás, M.A. Pastor, V. Olaso, J. Berenguer.
Síndrome carcinoide: avances en diagnóstico y tratamiento.
Rev Esp Enferm Dig, 91 (1999), pp. 61-69
[2.]
M.E. Caplin, J.R. Buscombe, A.J. Hilson, A.L. Jones, A.F. Watkinson, A.K. Burroughs.
Carcinoid tumour.
Lancet, 352 (1998), pp. 799-805
[3.]
M.E. Caplin, H.J. Hodgson, A.P. Dhillon, R. Begent, J. Buscombe, R. Dick, et al.
Multimodality treatment for gastric carcinoid tumor with liver metastases.
Am J Gastroenterol, 93 (1998), pp. 1945-1948
[4.]
W. Creutzfeldt.
Historical background and natural history of carcinoids.
Digestion, 55 (1994), pp. 3-10
[5.]
A. Sandor, I.M. Modlin.
A retrospective analysis of 1570 appendiceal carcinoids.
Am J Gastroenterol, 93 (1998), pp. 422-428
[6.]
J.A. Norton.
Surgical management of carcinoid tumors: role of debulking and surgery for patients with advanced disease.
Digestion, 55 (1994), pp. 98-103
[7.]
A.G. Harris, J.S. Redfern.
Octreotide treatment of carcinoid syndrome: analysis of published dose-titration data.
Aliment Pharmacol Ther, 9 (1995), pp. 387-394
[8.]
M.H. Kulke, R.J. Mayer.
Carcinoid tumors.
N Engl J Med, 340 (1999), pp. 858-868
[9.]
P.C. Neary, P.H. Redmond, T. Houghton, G.R.K. Watson, D. Bouchier-Hayes.
Carcinoid disease. Review of the literature.
Dis Colon Rectum, 40 (1997), pp. 349-362
[10.]
C.J. Gilligan, G.P. Lawton, L.H. Tang, A.B. West, I.M. Modlin.
Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion.
Am J Gastroenterol, 90 (1995), pp. 338-352
[11.]
M.A. Memon, H. Nelson.
Gastrointestinal carcinoid tumors. Current management strategies.
Dis Colon Rectum, 40 (1997), pp. 1101-1118
[12.]
D. Granberg, E. Wilander, M. Stridsberg, G. Granerus, B. Skogseid, K. Öberg.
Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids.
Gut, 43 (1998), pp. 223-228
[13.]
P. Tomassetti, M. Migliori, G.C. Caletti, P. Fusaroli, R. Corinaldesi, L. Gullo.
Treatment of type II gastric carcinoid tumors with somatostatin analogues.
N Engl J Med, 343 (2000), pp. 551-554
[14.]
H. Ahlman, L. Kölby, L. Lundell, L. Olbe, B. Wängberg, G. Granérus, et al.
Clinical management of gastric carcinoid tumors.
Digestion, 55 (1994), pp. 77-85
[15.]
I.M. Modlin, C.J. Gilligan, G.P. Lawton, L.H. Tang, A.B. West, U. Darr.
Gastric carcinoids. The yale experience.
Arch Surg, 130 (1995), pp. 250-255
[16.]
S. Rappel, A. Altendorf-Hofmann, M. Stolte.
Prognosis of gastric carcinoid tumours.
Digestion, 56 (1995), pp. 455-462
[17.]
B.I. Hirschowitz, J. Griffith, D. Pellegrin, O.W. Cummings.
Rapid regression of enterochromaffinlike cell gastric carcinoids in pernicious anemia after antrectomy.
Gastroenterology, 102 (1992), pp. 1409-1418
[18.]
M. Rothmund, O. Kisker.
Surgical treatment of carcinoid tumors of the small bowel, appendix, colon and rectum.
Digestion, 55 (1994), pp. 86-91
[19.]
A. Roggo, W.C. Wood, L.W. Ottinger.
Carcinoid tumors of the appendix.
Ann Surg, 217 (1993), pp. 385-390
[20.]
S.J. Connor, G.B. Hanna, F.A. Frizelle.
Retrospective clinicopathologic anaysis of appendiceal tumors from 7970 appendectomies.
Dis Colon Rectum, 41 (1998), pp. 75-80
[21.]
P. Sauven, J.A. Ridge, S.H. Quan, E.R. Sigurdson.
Anorectal carcinoid tumors.
Ann Surg, 211 (1990), pp. 67-71
[22.]
K. Matsui, T. Iwase, M. Kitagawa.
Small, polypoid-appearing carcinoid tumors of the rectum: clinicopathologic study of 16 cases and effectiveness of endoscopic treatment.
Am J Gastroenterol, 85 (1993), pp. 1949-1953
[23.]
Y. Imada-Shirakata, M. Sakai, T. Kajiyama, G. Kin, K. Inoue, A. Torii, et al.
Endoscopic resection of rectal carcinoid tumors using aspiration lumpectomy.
Endoscopy, 28 (1996), pp. 34-38
[24.]
S. Higaki, M. Nishiaki, N. Mitani, H. Yanai, M. Tada, K. Okita.
Effectiveness of local endoscopic resection of rectal carcinoid tumors.
Endoscopy, 29 (1997), pp. 171-175
[25.]
A.B. Jetmore, J.E. Ray, J.B. Gathright, K.M. McMullen, T.C. Hicks, A.E. Timmcke.
Rectal carcinoids: the most frequent carcinoid tumor.
Dis Colon Rectum, 35 (1992), pp. 717-725
[26.]
A.N. Koura, G.G. Glacco, S.A. Curley, J.M. Skibber, B.W. Feig, L.M. Ellis.
Carcinoid tumors of the rectum. Effect of size, histopathology, and surgical treatment on metastasis free survival.
Cancer, 79 (1997), pp. 1294-1298
[27.]
K. Shirouzu, H. Isomoto, T. Kakegawa.
Treatment of rectal carcinoid tumors.
Am J Surg, 160 (1990), pp. 262-265
[28.]
H. Ishikawa, K. Imanishi, S. Otani, M. Tatsuta, S. Ishiguro.
Effectiveness of endoscopic treatament of carcinoid tumors of the rectum.
Endoscopy, 21 (1989), pp. 133-135
[29.]
T. Matsumoto, M. Iida, H. Suekane, M. Tominaga, T. Yao, M. Fujishima.
Endoscopic ultrasonograpy in rectal carcinoid tumors: contribution to selection of therapy.
Gastrointest Endosc, 37 (1991), pp. 539-542
[30.]
M. Gregor.
Therapeutic principles in the management of metastasising carcinoid tumors: drugs for symptomatic treatment.
Digestion, 55 (1994), pp. 60-63
[31.]
K. Öberg, B. Erikson.
The role of interferons in the management of carcinoid tumours.
Br J Haematol, 79 (1991), pp. 74-79
[32.]
S.B. Saslow, J.S. Scolapio, M. Camilleri, S. Forstrom, G.M. Thomforde, D.D. Burton, et al.
Medium term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea.
Gut, 42 (1998), pp. 628-634
[33.]
S. Halford, J. Waxman.
The management of carcinoid tumours.
Q J Med, 91 (1998), pp. 795-798
[34.]
A. Pazos, I. Mediadores celulares.
Histamina y 5-hidroxitriptamina. Farmacología de la migraña.
Farmacología humana. 3.a ed, pp. p305-p325
[35.]
H. Schwörer, Münke, F. Stöckmann, G. Ramador.
Treatment of diarrhea in carcinoid syndrome with ondansetron, tropisetron and clonidine.
Am J Gastroenterol, 90 (1995), pp. 645-648
[36.]
R. Arnol, M.E. Trautmann, W. Creutzfeldt, R. Benning, M. Bennig, C. Neuhaus, et al.
Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours.
Gut, 38 (1996), pp. 430-438
[37.]
M. Di Bartolomeo, E. Bajetta, R. Buzzoni, L. Mariani, C. Carnaghi, L. Somma, et al.
Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors.
Cancer, 77 (1996), pp. 402-408
[38.]
R. Arnold, M. Frank, U. Kajdan.
Management of gastroenteropancreatic endocrine tumors: the place of somatostatin analogues.
Digestion, 55 (1994), pp. 107-113
[39.]
K. Öberg, B. Erikson, E.T. Janson.
Interferons alone or in combination with chemotherapy or other biologicals in the treatment of neuroendocrine gut and pancreatic tumors.
Digestion, 55 (1994), pp. 64-69
[40.]
M. Frank, K.J. Klose, M. Wied, N. Ishaque, C. Schade-Brittinger, R. Arnol.
Combination therapy with octreotide and alpha-interferon: effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors.
Am J Gastroenterol, 94 (1999), pp. 1381-1387
[41.]
P. Ruszniewskj, M. Ducreux, J.A. Chayvialle, J. Blumberg, D. Cloarec, H. Michel, et al.
Treatment of the carcinoid syndrome with the long acting somatostatin analogue lanreotide: a prospective study in 39 patients.
Gut, 39 (1996), pp. 279-283
[42.]
P. Tomassetti, M. Migliori, L. Gullo.
Slow-release lanreotide treatment in endocrine gastrointestinal tumors.
Am J Gastroenterol, 93 (1998), pp. 1468-1471
[43.]
G.P. McEntee, D.M. Nagorney, L.K. Kvols, C.G. Moertel, C.S. Grant.
Cytoreductive hepatic surgery for neuroendocrine tumors.
Surgery, 108 (1990), pp. 1091-1096
[44.]
H. Ahlman.
The role of surgery in patients with advanced midgut carcinoid tumours.
Digestion, (1996), pp. 86-87
[45.]
M.E. Clouse, L. Perry, K. Stuart, K.R. Stokes.
Hepatic arterial chemoembolization for metastatic neuroendocrine tumors.
Digestion, 55 (1994), pp. 92-97
[46.]
T. Casanovas.
Trasplante hepático en los tumores primitivos y metastásicos del hígado exceptuando el hepatocarcinoma.
Gastroenterol Hepatol, 24 (2001), pp. 75-78
[47.]
A. Frilling, X. Rogiers, W.T. Knöfel, C.E. Broelsch.
Liver transplantation for metastatic carcinoid tumors.
Digestion, 55 (1994), pp. 104-106
[48.]
A. Chakravarthy, R.A. Abrams.
Radiation therapy in the management of patients with malignant carcinoid tumors.
Cancer, 75 (1995), pp. 1386-1390
[49.]
M.B. Jacobsen, L.E. Hanssen, R. Kolmannskog, E. Schrumpf, M.H. Vain, A. Bergan.
Interferon-alpha-2b, with or without prior hepatic artery embolization: clinical response and survival in midgut carcinoid patients. The Norwegian carcinoid study.
Scand J Gastroenterol, 30 (1995), pp. 789-796
Copyright © 2002. Elsevier España, S.L.. Todos los derechos reservados